A. James (Jim) Moser, MD, FACS, has joined the Division of Surgical Oncology in the Roberta and Stephen R. Weiner Department of Surgery as Executive Director of the new Institute for Hepatobiliary and Pancreatic Surgery at Beth Israel Deaconess Medical Center.
Moser comes to BIDMC from the University of Pittsburgh Medical Center (UPMC), where he was a staff surgeon in the Division of Surgical Oncology and Co-Director of the multidisciplinary UPMC Pancreatic Cancer Center. He was also Associate Professor of Surgery and Associate Professor of Cell Biology and Physiology at the University of Pittsburgh School of Medicine.
A graduate of Washington University School of Medicine in St. Louis, MO, Moser completed a residency in general surgery and a research fellowship in membrane biology at UCLA Center for Health Sciences and UCLA School of Medicine in Los Angeles, CA.
Moser serves as Executive Director of BIDMC’s new Institute for Hepatobiliary and Pancreatic Surgery, providing leadership, strategic vision and integration of programs in general surgery, surgical oncology and transplant surgery that are focused on the surgical treatment of benign and malignant pancreatic, hepatic and biliary diseases. He has advanced surgical training and is a leader in complex, advanced robotic and minimally-invasive surgical oncology including pancreatic auto-islet transplantation.
Quotes from Dr. Moser:
Our objective is to leverage the intellectual and entrepreneurial assets of Harvard to improve the futures of people affected by pancreatic cancer – wherever they are.”
The emphasis of any pancreatic cancer program is reaching people and bringing personalized treatment to them.”
The problem with fundraising for pancreatic cancer is the lack of enduring champions since the disease takes affected people so quickly. Efforts to increase the visibility of pancreatic cancer are stunted by the emotional toll which the disease has on surviving family members. There is no method to detect the disease early like mammography, meaning that awareness is not reinforced and diagnosis is often too late.”
It is important to teach doctors and basic scientists to work together and then harness their talents in new ways.”
Disclaimer: The Alliance of Families Fighting Pancreatic Cancer has no official affiliation or sponsorship agreement with any of the entities whose names or marks are used on this website.